Congress of psychiatry
Download 0.5 Mb. Pdf ko'rish
|
PROGRAMME 170 S-230 Symposium 08:15 – 09:45 | Room M2 / M3 TOPIC 5: Neurotic, stress-related and somatoform disorders Health care of OCD from the patient and profes- sional perspective: progress and challenges for the future Chairs: Antonia Peters, Germany Michael Zaudig, Germany 001 The prevalence of OCD and OCD spectrum disorders Michael Zaudig, Germany 002 OCD from the patient's perspective Oliver Sechting, Germany 003 Intensive outpatient exposure in the treatment of OCD Thomas Hillebrand, Germany 004 Intensive inpatient treatment of severe OCD: short- and long-term efficacy Ulrich Voderholzer, Germany S-231 Symposium 08:15 – 09:45 | Room M4 / M5 TOPIC 23: Health care research and models, health care policy Arts therapies – an international overview › DGPPN Section: Health Care Professions › DGPPN Section: Psychosocial Care Research Chairs: Kathrin Seifert, Germany Thomas Becker, Germany 001 Art therapy and mental illness – a health promotion perspective Patricia Fenner, Australia 002 Rawda Said Abdelazim, Egypt 003 Dance movement therapy research findings and perspectives in Germany, Switzerland and Egypt Iris Bräuninger, Switzerland Rawda Said Abdelazim 004 An update on music therapy research in psychiatry Gitta Strehlow, Germany 005 The arts therapies in the treatment of depression: what evidence do we have? Vicky Karkou, United Kingdom Ania Zubala S-232 Symposium 08:15 – 09:45 | Room M1 TOPIC 25: Training and continuing education How psychoanalysis can contribute to psychiatric education › WPA Section: Psychoanalysis in Psychiatry › ZONE 6: Western Europe Chairs: Michel Botbol, France Graciela Beatriz Onofrio, Argentina 001 Contribution of psychoanalysis to pharmaco- therapy education and training Allan Tasman, USA 002 How psychiatric education should care about psychiatrists' mental health Aldo Suarez, Mexico 003 Programs on medical education for psychiatrists: the psychopathology of everyday life nowadays Graciela Beatriz Onofrio, Argentina 004 Education and training in psychotherapy for personality disorders Dusica Lecic-Tosevski, Serbia S-233 Symposium 08:15 – 09:45 | Room Weimar 3 TOPIC 3: Psychotic disorders Novel approaches to managing obesity and metabolic disturbances in anti-psychotics-treated patients Chairs: Margaret Hahn, Canada Bjorn Ebdrup, Denmark 001 Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: a pilot randomised controlled trial Dan Siskind, Australia 002 Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist: results from an investigator-initiated prospective, randomized, pla- cebo-controlled, double-blinded intervention study (The TAO study) Bjorn Ebdrup, Denmark 003 Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? A randomised, double-blinded, place- bo-controlled clinical trial Anders Fink-Jensen, Denmark MOND A Y TUESD A Y WEDNESD A Y THURSD A Y German language Session Q & A Modul SCIENTIFIC PROGRAMME 171 S-234 Symposium 08:15 – 09:45 | Room Weimar 1 TOPIC 16: Diagnostics and classification, psychopathology, RDoC The development of the Latin American guide to psychiatric diagnosis (GLADP) and other integrative diagnostic models › WPA Section: Classification, Diagnostic Assessment & Nomenclature Chairs: Ihsan Salloum, USA Juan E. Mezzich, USA 001 Conceptual aspects of the Latin American Guide to Psychiatric Diagnosis (GLADP) Juan E. Mezzich, USA 002 The Person-centered Diagnostic model (PID) and the Latin American Guide to Psychiatric Diagnosis (GLADP) Ihsan Salloum, USA 003 Latin American annotation of the Latin American Guide to Psychiatric Diagnosis (GLADP) Elvia Velasquez, Colombia 004 Demonstration of the application of the Latin American Guide to Psychiatric Diagnosis (GLADP) through a clinical Ybeth Luna, Peru S-235 Symposium 08:15 – 09:45 | Room Lindau 6 TOPIC 7: Personality disorders Joint WAIMH and perinatal section invited sympo- sium: psychopathology and its impact on parenting › WPA Section: Perinatal Psychiatry and Infant Mental Health Chairs: Miri Keren, Israel Kai von Klitzing, Germany 001 Overview of the impact of parental psychology on young children and its link with preschoolers' depression Kai von Klitzing, Germany 002 The impact of parental OCD and depression on parenting behaviors Miri Keren, Israel 003 Impact of borderline personality disorder, with or without chronic depression on offsprings Gisèle Apter, France 004 The impact of eating disorders during infancy on the co-parenting Massimo Ammaniti, Italy S-236 Symposium 08:15 – 09:45 | Room Dessau 6 TOPIC 40: Mass media and mental health Some positive and hazardous uses of electronic technologies and women's mental health › ZONE 1: Canada › ZONE 4: Northern South America Chairs: Donna E. Stewart, Canada Josyan Madi-Skaff, Lebanon 001 The Mental Health eClinic (MHeC) connecting young people to the right services at the right time Laura Ospina Pinillos, Australia Tracey Davenport, Frank Iorfino, Elizabeth Scott, Jane Burns, Ian Hickie 002 Electronic technologies and perinatal outcomes Silvia Gaviria, Colombia 003 Cyberbullying Virginia Rosabal, Costa Rica 004 Internet romance scams Donna E. Stewart, Canada S-237 Symposium 08:15 – 09:45 | Room R2 TOPIC 9: Comorbidity of somatic and mental disorders, psychosomatics Transcultural problems of mental health of the indigenous population of Siberia and the Far East: clinical, biological heterogeneity and comorbidity Chairs: Nikolay Bokhan, Russia Irina Kupriyanova, Russia 001 Mental health and problems of comorbidity of addictive states among indigenous population of Siberia and Far East Nikolay Bokhan, Russia D. I. Kurgak, Alexei Kostin 002 Mental health of adolescents in China and Siberia Hu Jian, People's Republic of China Irina Kupriyanova, Na Zhao, Bairma Dashieva, Irina Karaush, T. I. Ivanova 003 Personality factor in formation of mental and physical interrelations Sagat Altynbekov, Kazakhstan Valentina Lebedeva, Nikolay Bokhan, Tatiana Bokhan 004 Mental disorders and possibilities of ethno- culturally conditioned rehabilitation of disabled children Irina Kupriyanova, Russia Bairma Dashieva MOND A Y TUESD A Y WEDNESD A Y THURSD A Y SCIENTIFIC PROGRAMME 172 S-238 Symposium 08:15 – 09:45 | Room R3 TOPIC 32: Violence and trauma Pathologies by disruption, clinical issues, neuro- physiology, treatments and interventions › WPA Section: Disaster Psychiatry Chairs: Jose Toufic Thomé, Brazil Irene Onik, Argentina 001 Reconstructive Relational Experience (RRE) as a model of crisis and disaster intervention, based on human factors Jose Toufic Thomé, Brazil 002 Disaster recovery in the United Nations agenda: the way forward for the psychiatric community in the implementation – indicators and advocacy at the United Nations and on the ground Judy Kuriansky, USA 003 Post traumatic stress disorder is a unique noso- logical entity? Neurophysiology and clinical issues Irene Onik, Argentina Maria Silvana Goncalves 004 The War of Malvinas, relatives of fallen, a long and solitary road of 35 years Enrique Stein, Argentina S-239 Symposium 08:15 – 09:45 | Room R13 TOPIC 23: Health care research and models, health care policy Innovation in health care: examples from Germany Chairs: Iris Hauth, Germany Sabine Köhler, Germany 001 § 64b SGB V-Models resp. regional budgets Arno Deister, Germany 002 Psychiatry Initiative Berlin Brandenburg (PIBB) Norbert Mönter, Germany 003 Hamburg model for people with severe mental illnesses Martin Lambert, Germany 004 Network mental health (NWpG) Nils Greve, Germany 005 Relevant aspects of psychiatric-care models – an overview Sabine Köhler, Germany S-061 (d) Symposium (German) 08:15 – 09:45 | Hall A3 TOPIC 28: History, art and cultural sciences Die Psychiatrie und das Fremde – kulturwissen- schaftliche Perspektiven Chairs: Henning Saß, Germany Matthias Bormuth, Germany 001 Das Fremde als Herausforderung – Überlegungen zur Ethnopsychopathologie Matthias Bormuth, Germany 002 Das Eigene und das Fremde in der Identitäts- entwicklung – zugleich ein Beitrag zur Adoleszenz Thomas Fuchs, Germany 003 Bilder des Fremden in der Psychiatrie am Beispiel von Kraepelin, Bleuler und Storch Andreas Heinz, Germany 004 Der Fremde oder der Andere – Überlegungen zur Interpersonalität Paul Hoff, Switzerland S-062 (d) Symposium (German) 08:15 – 09:45 | Hall Berlin 2 TOPIC 1: Neurocognitive disorders, organic mental disorders, dementia Funktionelle Bildgebung im Alter Chairs: Florian Metzger, Germany Martin Herrmann, Germany 001 MRT und Plastizitätsmessung Jessica Peter, Germany 002 Früherkennung prodromaler Alzheimer-Krank- heit mittels multizentrischer Ruhe-fMRT – Ergeb- nisse der Multisite resting-state fMRI Initiative (PsyMRI) Martin Dyrba, Germany Coraline Metzger, Timo Grimmer, Christian Sorg, Michael Ewers, Eva Meisenzahl, Stefan Klöppel, Viola Borchardt, Michel Grothe, Stefan Teipel 003 fNIRS – physiologische und pathologische Korrelate des Alterns Florian Metzger, Germany 004 Funktionelle Bildgebung bei leichter kognitiver Beeinträchtigung und genetischen Risikofaktoren Martin Herrmann, Germany MOND A Y TUESD A Y WEDNESD A Y THURSD A Y German language Session Q & A Modul SCIENTIFIC PROGRAMME 173 S-063 (d) Symposium (German) 08:15 – 09:45 | Hall London 1 TOPIC 18: Pharmacotherapy Unterstützung einer rationalen und rationellen Arzneimitteltherapie › AGATE – Arbeitsgemeinschaft Arzneimitteltherapie bei psychiatrischen Erkrankungen e.V. Chairs: Ekkehard Haen, Germany Irene Berti, Italy 001 Verordnung von Antipsychotika 2009–2016 Benedikt Stegmann, Germany 002 Leukopenie – Thrombopenie – Eosinophilie: UAW an den blutbildenden Organen Armin Gerbitz, Germany 003 Der klinisch-pharmakologische Befund zu einer Wirkstoffkonzentration Ekkehard Haen, Germany 004 Wirkstoffkonzentrationsbestimmungen zur Therapieleitung unter Depot-Antipsychotika (LAI) Andreas Conca, Italy Daria Piacentino, Fabio Carpi S-064 (d) Symposium (German) 08:15 – 09:45 | Room Lindau 3 TOPIC 20: Prevention and health promotion Vom Behandelten zum Handelnden – Erfah- rungsexperten (people with lived experience) in innovativen Settings Chairs: Martin Schultz, Germany Uwe Wegener, Germany 001 Peer in der Praxis / Peers in Praxen Uwe Wegener, Germany 002 Peers im betrieblichen Setting (Teil 1) Martin Schultz, Germany 003 Peers im betrieblichen Setting (Teil 2) Manfred Schneider, Germany 004 Peers in Schulen / Hochschule (Teil 1) Imke Schrader, Germany 005 Peers in Schulen / Hochschule (Teil 2) Katharina Pretscher, Germany WS-21 Workshop 08:15 – 09:45 | Room M8 TOPIC 19: Stimulation methods and interdisciplinary interventions Basic concepts of rTMS, gauging effectiveness of rTMS effects plus possible neuroanatomical correlates and hands-on training Chairs: Adel Marei, Egypt Jakob Kaminski, Germany Speaker: Hussien Elkholy, Egypt WS-22 Workshop 08:15 – 09:45 | Room M6 TOPIC 25: Training and continuing education Teaching psychopharmacology in low and middle in- come countries (LAMIC): a WPA / AACP collaboration Chairs: Driss Moussaoui, Morocco Sidney Zisook, USA OS-38 Oral Presentation Session 08:15 – 09:45 | Room R12 TOPIC 18: Pharmacotherapy Pharmacotherapy Chairs: Gerhard Gründer, Germany Alex Hofer, Austria 001 Risks associated with first-trimester pregnancy exposure to duloxetine Niels Bergemann, Germany Wolfgang E. Paulus 002 An investigation of cardiovascular risks in a group of children and adolescents who use atypical antipsychotics Gül Dikec, Turkey Leyla Baysan Arabaci, Gulcin Uzunoglu, Selin Demet Mizrak 003 Arterial hyper- and hypotension associated with psychiatric medications: a risk assessment based on the German summaries of product characteristics (SmPCs) Roland Freudenmann, Germany Bartosz Zurowski, Carlos Schönfeldt-Lecuona, Ludwig Maier, Christian Lange-Asschenfeldt, Maximilian Gahr 004 Bacloville: a clinical efficacy study of high dose baclofen in reducing alcohol consumption in high risk drinkers Philippe Jaury, France Stéphanie Sidorkiewicz MOND A Y TUESD A Y WEDNESD A Y THURSD A Y SCIENTIFIC PROGRAMME 174 005 Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a randomized, open-label study Rayees Wani, India Mansoor Dar 006 Clozapine-associated neutropenia and agran- ulocytosis: results form the pharmacovigilance intensive program in Argentina Federico Daray, Argentina María Victoria Balda, Cintia Romina Prokopez, Arnaldo Armesto OS-39 Oral Presentation Session 08:15 – 09:45 | Room R4 TOPIC 4: Affective disorders Affective disorders: treatment and interventions I Chairs: Gregor Hasler, Switzerland Erich Seifritz, Switzerland 001 Hospital and day hospital treatments for patients with major depression: psychotherapeutic program and main results of the INDDEP-study Jörn von Wietersheim, Germany Armin Hartmann, Heinz Weiss, Carl-Eduard Scheidt, Alexander Völker, Annegret Eckhardt-Henn, Manfred Beutel, Jamie Knoblauch, Peter Rochlitz, Almut Zeeck 002 Who responds to therapeutic sleep deprivation? A large naturalistic clinical study Nina Trautmann, Germany Jerome Foo, Josef Frank, Steffen Conrad von Heydendorff, Maria Gilles, Stephanie H. Witt, Michael Deuschle, Marcella Rietschel 003 Metacognitive training for depression: new results and developments Lena Jelinek, Germany Sönke Arlt, Anne Runde, Jürgen Gallinat, Steffen Moritz, Simone Kühn, Judith Peth 004 Antidepressant treatment effects on dopamine transporter availability in patients with major depression: a prospective 123I-FP-CIT SPECT imaging genetic study Sabine Hellwig, Germany Lars Frings, Annette Masuch, Werner Vach, Katharina Domschke, Claus Normann, Philipp T. Meyer 005 Is psychoeducational family intervention feasible in the Italian mental health centres? Findings from an Italian multicentric study Gaia Sampogna, Italy Mario Luciano, Benedetta Pocai, Micaela Savorani, Giuseppina Borriello, Valeria Del Vecchio, Vincenzo Giallonardo, Andrea Fiorillo 006 Sahaj Samadhi Meditation, belonging to the category of Automatic Self Transcending Meditation (ASTM), improves symptoms of late-life depression Akshya Vasudev, Canada Emily Ionson, Amer Burhan, Ronnie Newman OS-40 Oral Presentation Session 08:15 – 09:45 | Room R5 TOPIC 13: Brain imaging, neurophysiology, neuropsychology Brain imaging, neurophysiology, neuropsychology III Chairs: Armida Mucci, Italy Oliver Gruber, Germany 001 Hippocampal mean diffusivity for the diagnosis of dementia and mild cognitive impairment in a primary care sample Katharina Brüggen, Germany Martin Dyrba, Ingo Kilimann, Wolfgang Hoffmann, Jochen R. Thyrian, Stefan Teipel 002 Modulation of short- and long-term memory with stimulants: a fMRI study on the cognitive effects of methylphenidate, caffeine and modafinil on healthy male individuals Dimitris Repantis, Germany Lucas Adam, Martin Dresler, Simone Kuehn 003 Emotion recognition and emotion regulation in a person with a unilateral amygdala lesion Katrin Schulze, Germany Sven Barnow 004 Neurobiology of trait impulsivity: a comparative VBM study contrasting traditional and alternative concepts Bianca Besteher, Germany Christian Gaser, Igor Nenadic 005 Seed-based resting-state functional connec- tivity in patients with persistent somatoform pain disorder (PSPD) Yanli Luo, People's Republic of China Xiandi Pan, Chao Yan, Tianming Huang 006 Normative data for Cambridge Neuropsy- chological Test Automated Battery (CANTAB) for Sri Lankans: changes of cognitive functions from adolescence to late adulthood Dewasmika Ariyasinghe, Sri Lanka R. G. L. Shiroma, Subhagya Kulatunga, Tharaka Dassanayake MOND A Y TUESD A Y WEDNESD A Y THURSD A Y German language Session Q & A Modul SCIENTIFIC PROGRAMME 175 OS-41 Oral Presentation Session 08:15 – 09:45 | Room R6 TOPIC 44: Other topics Other topics Chairs: Cornelis J. Kees Laban, The Netherlands Iris Tatjana Graef-Calliess, Germany 001 Creating synergies between mental health professionals and the mental health first person movement: experiences from training and sensitization Francisco José Eiroa-Orosa, Spain Download 0.5 Mb. Do'stlaringiz bilan baham: |
Ma'lumotlar bazasi mualliflik huquqi bilan himoyalangan ©fayllar.org 2024
ma'muriyatiga murojaat qiling
ma'muriyatiga murojaat qiling